Long-term high fat feeding of rats results in increased numbers of circulating microvesicles with pro-inflammatory effects on endothelial cells.

Obesity and type 2 diabetes lead to dramatically increased risks of atherosclerosis and CHD. Multiple mechanisms converge to promote atherosclerosis by increasing endothelial oxidative stress and up-regulating expression of pro-inflammatory molecules. Microvesicles (MV) are small ( < 1 μm) circulating particles that transport proteins and genetic material, through which they are able to mediate cell-cell communication and influence gene expression. Since MV are increased in plasma of obese, insulin-resistant and diabetic individuals, who often exhibit chronic vascular inflammation, and long-term feeding of a high-fat diet (HFD) to rats is a well-described model of obesity and insulin resistance, we hypothesised that this may be a useful model to study the impact of MV on endothelial inflammation. The number and cellular origin of MV from HFD-fed obese rats were characterised by flow cytometry. Total MV were significantly increased after feeding HFD compared to feeding chow (P< 0·001), with significantly elevated numbers of MV derived from leucocyte, endothelial and platelet compartments (P< 0·01 for each cell type). MV were isolated from plasma and their ability to induce reactive oxygen species (ROS) formation and vascular cell adhesion molecule (VCAM)-1 expression was measured in primary rat cardiac endothelial cells in vitro. MV from HFD-fed rats induced significant ROS (P< 0·001) and VCAM-1 expression (P= 0·0275), indicative of a pro-inflammatory MV phenotype in this model of obesity. These findings confirm that this is a useful model to further study the mechanisms by which diet can influence MV release and subsequent effects on cardio-metabolic health.

[1]  Paul Harrison,et al.  Classification, Functions, and Clinical Relevance of Extracellular Vesicles , 2012, Pharmacological Reviews.

[2]  Françoise Dignat-George,et al.  The Many Faces of Endothelial Microparticles , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[3]  M. Alessi,et al.  Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1. , 2007, The American journal of pathology.

[4]  R Lacroix,et al.  Standardization of pre‐analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop , 2013, Journal of thrombosis and haemostasis : JTH.

[5]  P. Libby,et al.  Immune effector mechanisms implicated in atherosclerosis: from mice to humans. , 2013, Immunity.

[6]  R. Pink,et al.  Routes and mechanisms of extracellular vesicle uptake , 2014, Journal of extracellular vesicles.

[7]  S. Son Reactive Oxygen and Nitrogen Species in Pathogenesis of Vascular Complications of Diabetes , 2012, Diabetes & metabolism journal.

[8]  M. Cybulsky,et al.  Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. , 1999, Circulation research.

[9]  P. Nusbaum,et al.  Distinct Signaling Pathways Are Involved in Leukosialin (CD43) Down-regulation, Membrane Blebbing, and Phospholipid Scrambling during Neutrophil Apoptosis* , 2005, Journal of Biological Chemistry.

[10]  L. Ragolia,et al.  Circulating Endothelial Microparticles in Diabetes Mellitus , 2010, Mediators of inflammation.

[11]  G. King,et al.  The role of protein kinase C activation and the vascular complications of diabetes. , 2007, Pharmacological research.

[12]  G. Holtrop,et al.  Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status , 2014, Journal of Thrombosis and Thrombolysis.

[13]  G. Pasterkamp,et al.  Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease , 2014, Cardiovascular Diabetology.

[14]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[15]  Chantal M Boulanger,et al.  Microparticles From Human Atherosclerotic Plaques Promote Endothelial ICAM-1–Dependent Monocyte Adhesion and Transendothelial Migration , 2011, Circulation research.

[16]  S. Faure,et al.  Microparticles from Patients with Metabolic Syndrome Induce Vascular Hypo-Reactivity via Fas/Fas-Ligand Pathway in Mice , 2011, PloS one.

[17]  D. Connor,et al.  The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib , 2010, Thrombosis and Haemostasis.

[18]  P. Schauer,et al.  Restoration of glycemic control in patients with type 2 diabetes mellitus after bariatric surgery is associated with reduction in microparticles. , 2013, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[19]  M. Zarrindast,et al.  Elevated CSF and plasma microparticles in a rat model of streptozotocin-induced cognitive impairment , 2013, Behavioural Brain Research.

[20]  J. Millán,et al.  TNF-induced endothelial barrier disruption: beyond actin and Rho , 2014, Thrombosis and Haemostasis.

[21]  Yu Luo,et al.  Plasma Endothelial Microparticles and Their Correlation With the Presence of Hypertension and Arterial Stiffness in Patients With Type 2 Diabetes , 2012, Journal of clinical hypertension.

[22]  J. Usherwood,et al.  Microparticle formation after co‐culture of human whole blood and umbilical artery in a novel in vitro model of flow , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[23]  D. Yellon,et al.  Exosomes: Nanoparticles Involved in Cardioprotection? , 2014, Circulation research.

[24]  Robert J Freishtat,et al.  Adipocyte-derived Exosomal miRNAs: A Novel Mechanism for Obesity-Related Disease , 2014, Pediatric Research.

[25]  A. Chait,et al.  Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies , 2008, The Lancet.

[26]  M. Macey,et al.  Microparticle formation after exposure of blood to activated endothelium under flow , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[27]  S M Grundy,et al.  Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. , 1999, Circulation.

[28]  B. Spiegelman,et al.  IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.

[29]  Philip Greenland,et al.  Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations , 1999 .

[30]  R. Schiffelers,et al.  Toward routine detection of extracellular vesicles in clinical samples , 2014, International journal of laboratory hematology.

[31]  Y. Zou,et al.  Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. , 1994, The Journal of biological chemistry.

[32]  Tatiane Mieko de Meneses Fujii,et al.  A high-fat diet increases interleukin-3 and granulocyte colony-stimulating factor production by bone marrow cells and triggers bone marrow hyperplasia and neutrophilia in wistar rats , 2013, Experimental biology and medicine.

[33]  R. Fernandes,et al.  Metformin restores endothelial function in aorta of diabetic rats , 2011, British journal of pharmacology.

[34]  N. Ruderman,et al.  Protein Kinase C-&bgr; Contributes to Impaired Endothelial Insulin Signaling in Humans With Diabetes Mellitus , 2012, Circulation.

[35]  R. Nieuwland,et al.  Elevated Numbers of Tissue-Factor Exposing Microparticles Correlate With Components of the Metabolic Syndrome in Uncomplicated Type 2 Diabetes Mellitus , 2002, Circulation.

[36]  Jacqueline Capeau,et al.  Recent advances in the relationship between obesity, inflammation, and insulin resistance. , 2006, European cytokine network.

[37]  U. Kintscher,et al.  The endothelium and vascular inflammation in diabetes , 2007, Diabetes & vascular disease research.

[38]  R. Andriantsitohaina,et al.  Circulating microparticles from pulmonary hypertensive rats induce endothelial dysfunction. , 2010, American journal of respiratory and critical care medicine.

[39]  G. Mann,et al.  Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. , 2009, Cardiovascular research.

[40]  Ming Chen,et al.  Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus. , 2010, Atherosclerosis.

[41]  S. Msika,et al.  Microparticle increase in severe obesity: Not related to metabolic syndrome and unchanged after massive weight loss , 2013, Obesity.